ストックスクリーナーアプリを入手
2.07
0.00%
0.00
Bioharvest Sciences Inc (BHST) 最新ニュース
BioHarvest Sciences Inc. (NASDAQ:BHST) Just Reported And Analysts Have Been Cutting Their Estimates - simplywall.st
BHST Maintains Rating by Maxim Group -- Price Target Lowered to $5.00 - GuruFocus
BioHarvest Sciences Inc. Common Stock (NASDAQ: BHST) Stock Price, News & Analysis - Kalkine
BHST Maintained by Roth Capital -- Price Target Lowered to $8.00 - GuruFocus
BioHarvest at canaccord growth conference: scaling plant-cell platform By Investing.com - Investing.com Canada
BioHarvest Sciences: Patented cell culture platform secures $20–30M fragrance deal, targets $40M revenue and profitability - TradingView
BioHarvest at canaccord growth conference: scaling plant-cell platform - Investing.com
BioHarvest Sciences Inc reports results for the quarter ended June 30Earnings Summary - TradingView
BioHarvest Sciences (BHST) Q2 2026 Earnings Call Transcript - AOL.com
BioHarvest Sciences Inc (BHST) (Q2 2026) Earnings Call Highlights: Strategic Pivot to ... By GuruFocus - Investing.com Canada
BioHarvest Sciences Inc (BHST) (Q2 2026) Earnings Call Highlight - GuruFocus
BioHarvest Sciences Inc (BHST) (Q2 2026) Earnings Call Highlights: Strategic Pivot to ... - Yahoo Finance
What Could BioHarvest Sciences (NASDAQ:BHST) Quarterly Update Show? - Kalkine Media
BioHarvest Sciences Inc. Common Stock Q2 2026 Earnings Call Summary - Yahoo Finance
Earnings call transcript: BioHarvest Sciences posts smaller Q2 2026 loss By Investing.com - Investing.com Canada
BioHarvest Sciences cuts FY26 revenue guidance for CDMO and VINIA D2C - scanx.trade
Transcript : BioHarvest Sciences Inc., Q2 2026 Earnings Call, Aug 11, 2026 - marketscreener.com
BioHarvest Sciences Q2 Earnings Call Highlights - MarketBeat
BioHarvest Sciences: Secured first major CDMO contract and reaffirmed 2027 EBITDA breakeven despite revised 2026 guidance - TradingView
BioHarvest Sciences: Secured a transformative fragrance CDMO contract, driving revenue growth and 2027 EBITDA breakeven - TradingView
Earnings call transcript: BioHarvest Sciences posts smaller Q2 2026 loss - Investing.com
BioHarvest Sciences shares surge 11% after major fragrance manufacturing deal - Yahoo Finance
BioHarvest Sciences shares surge 11% on major fragrance deal By Investing.com - Investing.com Canada
BioHarvest Sciences Inc. (BHST) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance
BioHarvest secures fragrance manufacturing deal worth $20-30M By Investing.com - Investing.com Australia
BioHarvest secures first CDMO manufacturing dea... - pluang.com
BioHarvest Sciences shares surge 11% on major fragrance deal - Investing.com
BioHarvest Sciences: Q2 revenue up 3.8% to $8.8M; first CDMO deal signed; full-year guidance revised downward - TradingView
BioHarvest secures fragrance manufacturing deal worth $20-30M - Investing.com
BioHarvest Sciences Announces Q2 2026 Financial Results and Secures Inaugural CDMO Fragrance Manufacturing Contract for 20-Ton Production - Kalkine Media
BioHarvest Sciences Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
BioHarvest Sciences Lands Exclusive 20-Tonne Rare Fragrance Production Deal Worth $20–$30 Million - Kalkine Media
BioHarvest posts higher Q2 revenue, secures manufacturing deal for premium fragrance compound - Proactive financial news
Bioharvest Sciences Inc (BHST) Earnings Forecast: Future EPS & Revenue Growth Estimates - tradingkey.com
BioHarvest Sciences Announces Uplisting to the Nasdaq Global Market - 富途牛牛
BioHarvest Sciences (BHST) Holds Steady at $2.26, Trapped Between $2.15 Support and $2.37 ResistanceRetail Volume - dars.gov.et
Enterprise value to EBIT forward of BioHarvest Sciences, Inc. – FWB:8MV0 - TradingView
Price to sales forward of BioHarvest Sciences, Inc. – MUN:8MV0 - tradingview.com
BioHarvest Sciences CEO to Present at Canaccord Genuity 46th Annual Growth Conference in Boston - kalkine.ca
BioHarvest Sciences CEO to present at Canaccord Genuity conference - Proactive financial news
BioHarvest Sciences to Unveil Q2 2026 Financial Results on August 11, 2026 - Kalkine Media
BioHarvest CEO to discuss first 100 days and 2026 growth plan - Stock Titan
BioHarvest to report Q2 2026 earnings and host a conference call on August 11 - pluang.com
Bioharvest Sciences Inc (BHST) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Bioharvest Sciences Inc (BHST) Balance Sheet - TradingKey
Bioharvest Sciences Inc (BHST) Cash Flow - TradingKey
Bioharvest Sciences Inc (BHST) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
BioHarvest Sciences, Inc. Revenue Breakdown – LSX:A40C6G - TradingView
BioHarvest Sciences Inc. Revenue Breakdown – NASDAQ:BHST - TradingView
Bioharvest Sciences Inc (BHST) Income Statement - tradingkey.com
Bioharvest Sciences Inc (BHST) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Bioharvest Sciences Inc (BHST) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Bioharvest Sciences Inc (BHST) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
BHST|Bioharvest Sciences Inc|Price:1.920|Chg%:-0.080 - TradingKey
BHST|Bioharvest Sciences Inc|Price:2.075|Chg%:-0.025 - tradingkey.com
Bioharvest Sciences Inc (BHST) Valuation: PE, PB & Fair Value Analysis - TradingKey
BHST|Bioharvest Sciences Inc|Price:2.050|Chg%:+0.130 - TradingKey
Bioharvest Sciences Inc (BHST) Institutional Confidence - TradingKey
Enterprise value to revenue forward of BioHarvest Sciences, Inc. – MUN:8MV0 - TradingView
Bioharvest Sciences Inc (BHST) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Enterprise value to EBIT forward of BioHarvest Sciences, Inc. – DUS:8MV0 - TradingView
Market Sentiment Around Loss-Making BioHarvest Sciences Inc. (NASDAQ:BHST) - webull.com
Price to earnings forward of BioHarvest Sciences, Inc. – DUS:8MV0 - TradingView
BioHarvest Sciences Inc. (BHST) Slips 4% as Stock Tests Key Support LevelsOversold Bounce Ideas - dars.gov.et
BioHarvest Sciences (NASDAQ:BHST) Shares Down 0.7%Here's What Happened - MarketBeat
BioHarvest Sciences Inc. (BHST) Declines 2.81% as Stock Tests Support Near $2.63Blue Chip Entry Points - dars.gov.et
BioHarvest Sciences (BHST) secures $1.4M Israel AI R&D funding - Stock Titan
1.49%
2.54%
大文字化:
|
ボリューム (24 時間):